{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:11:32Z","timestamp":1761664292980,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ajg.2021.05.003","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T01:07:44Z","timestamp":1622682464000},"page":"151-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Inter-method variability of hepatitis B surface antigen quantification in a cohort of Egyptian patients with chronic hepatitis B virus"],"prefix":"10.1016","volume":"22","author":[{"given":"Mona","family":"Nasser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naglaa","family":"Zayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadeel","family":"Gamal Eldeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Abdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Younan","family":"Kabara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdy","family":"Elserafy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajg.2021.05.003_b0005","first-page":"94","article-title":"Hepatitis B virus infection the Egyptian situation","volume":"8","author":"El-Zayadi","year":"2007","journal-title":"Arab J Gastroenterol"},{"issue":"5","key":"10.1016\/j.ajg.2021.05.003_b0010","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/jmv.24412","article-title":"Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D","volume":"88","author":"Fouad","year":"2016","journal-title":"J Med Virol"},{"issue":"5\u20136","key":"10.1016\/j.ajg.2021.05.003_b0015","first-page":"579","article-title":"Controlled trial with human lymphoblastoid interferon among HBeAg and anti-HBe-positive chronic hepatitis B patients in Egypt","volume":"70","author":"El-Zayadi","year":"1995","journal-title":"J Egypt Public Health Assoc"},{"issue":"2","key":"10.1016\/j.ajg.2021.05.003_b0020","first-page":"56","article-title":"Liver biopsy and fibroscan to detect early histopathological changes in chronic HBV patients not candidate for treatment","volume":"7","author":"Maklad","year":"2014","journal-title":"Gastroenterol. Res."},{"issue":"12","key":"10.1016\/j.ajg.2021.05.003_b0025","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.cgh.2007.09.005","article-title":"Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response","volume":"5","author":"Chan","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.ajg.2021.05.003_b0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11901-019-00484-y","article-title":"Role of HBsAg testing in the management of patients with chronic HBV","volume":"18","author":"Hong","year":"2019","journal-title":"Curr Hepatol Rep"},{"issue":"27","key":"10.1016\/j.ajg.2021.05.003_b0035","first-page":"9178","article-title":"Hepatitis B surface antigen levels during natural history of chronic hepatitis B: a Chinese perspective study","volume":"20","author":"Zeng","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajg.2021.05.003_b0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12072-019-09998-5","article-title":"Use of HBsAg quantifcation in the natural history and treatment of chronic hepatitis B","volume":"14","author":"Mak","year":"2020","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.ajg.2021.05.003_b0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The Metavir Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2021.05.003_b0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jviromet.2003.10.002","article-title":"Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay","volume":"115","author":"Deguchi","year":"2004","journal-title":"J Virol Methods"},{"issue":"2","key":"10.1016\/j.ajg.2021.05.003_b0055","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1055\/s-2006-939751","article-title":"Hepatitis Be antigen negative chronic hepatitis B \u2013 natural history and treatment","volume":"26","author":"Hadziyannis","year":"2006","journal-title":"Semin Liver Dis"},{"issue":"4","key":"10.1016\/j.ajg.2021.05.003_b0060","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jcv.2010.12.008","article-title":"Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum","volume":"50","author":"Wursthorn","year":"2011","journal-title":"J Clin Virol"},{"issue":"1\u20132","key":"10.1016\/j.ajg.2021.05.003_b0065","first-page":"141","article-title":"Comparison between Elecsys HBsAg II and Architect assays for quantification of serum hepatitis B surface antigen in Chinese patients with chronic hepatitis B","volume":"61","author":"Liu","year":"2015","journal-title":"Clin Lab"},{"issue":"4","key":"10.1016\/j.ajg.2021.05.003_b0070","first-page":"287","article-title":"Comparison of the Elecsys HBsAg II assay and the architect assay for quantification of hepatitis B surface antigen in patients with chronic hepatitis B","volume":"24","author":"Karagoz","year":"2016","journal-title":"Infez Med"},{"issue":"2","key":"10.1016\/j.ajg.2021.05.003_b0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.11613\/BM.2015.015","article-title":"Lessons in biostatistics Understanding Bland Altman analysis","volume":"25","author":"Giavarina","year":"2015","journal-title":"Biochem Med"},{"key":"10.1016\/j.ajg.2021.05.003_b0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.11613\/BM.2007.002","article-title":"What we need to know when calculating the coefficient of correlation?","volume":"17","author":"Udovi\u010di\u0107","year":"2007","journal-title":"Biochem Med"},{"issue":"3","key":"10.1016\/j.ajg.2021.05.003_b0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jcv.2011.04.005","article-title":"A comparison of two assays for quantification of Hepatitis B surface antigen in patients with chronic hepatitis B","volume":"51","author":"Sonneveld","year":"2011","journal-title":"J Clin Virol"},{"issue":"3","key":"10.1016\/j.ajg.2021.05.003_b0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cld.2013.05.006","article-title":"HBsAg quantification to predict natural history and treatment outcome in chronic hepatitis B patients","volume":"17","author":"Martinot-Peignoux","year":"2013","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1016\/j.ajg.2021.05.003_b0095","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/hep.23571","article-title":"Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers","volume":"51","author":"Thompson","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.ajg.2021.05.003_b0100","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1478-3231.2011.02516.x","article-title":"The change of the quantitative HBsAg level during the natural course of chronic hepatitis B","volume":"31","author":"Kim","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.ajg.2021.05.003_b0105","doi-asserted-by":"crossref","unstructured":"EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol 2017;67:370\u201398.","DOI":"10.1016\/j.jhep.2017.03.021"},{"issue":"1","key":"10.1016\/j.ajg.2021.05.003_b0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12072-015-9657-6","article-title":"Role of serum hepatitis B virus marker quantitation to differentiate natural history phases of HBV infection","volume":"10","author":"Wang","year":"2016","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.ajg.2021.05.003_b0115","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.diagmicrobio.2015.02.005","article-title":"Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state?","volume":"82","author":"Sali","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.ajg.2021.05.003_b0120","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.gastro.2010.04.052","article-title":"Hepatitis B surface antigen serum levels help to distinguish active from in active hepatitis B virus genotype D carriers","volume":"139","author":"Brunetto","year":"2010","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ajg.2021.05.003_b0125","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2010.01.007","article-title":"Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia","volume":"52","author":"Nguyen","year":"2010","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.ajg.2021.05.003_b0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jceh.2016.07.002","article-title":"Clinical significance of quantitative HBsAg titres and its correlation with HBV DNA levels in the natural history of hepatitis B virus Infection","volume":"6","author":"Karra","year":"2016","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.ajg.2021.05.003_b0135","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.12659\/MSM.905445","article-title":"Clinical characteristics and correlation analysis of subjects with chronic hepatitis B virus (HBV) infection and sustained low levels of hepatitis B surface antigen (HBsAg)","volume":"24","author":"Cheng","year":"2018","journal-title":"Med Sci Monit"},{"issue":"4","key":"10.1016\/j.ajg.2021.05.003_b0140","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/hep.23803","article-title":"A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B","volume":"52","author":"Chan","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2021.05.003_b0145","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2036.2011.04738.x","article-title":"Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy","volume":"34","author":"Liang","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.ajg.2021.05.003_b0150","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/17512433.2019.1567327","article-title":"Novel developments of hepatitis B: treatment goals, agents and monitoring tools","volume":"12","author":"Mak","year":"2019","journal-title":"Expert Rev Clin Pharmacol"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197921000253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197921000253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:41:51Z","timestamp":1761658911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197921000253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1687197921000253"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2021.05.003","relation":{},"ISSN":["1687-1979"],"issn-type":[{"type":"print","value":"1687-1979"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inter-method variability of hepatitis B surface antigen quantification in a cohort of Egyptian patients with chronic hepatitis B virus","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2021.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}